REPORT ID 2234

Global Human Coagulation Factor VIII Market Research Report 2017

Publish Date
8-Dec-17
Pages
110
Format
Electronic (PDF)

In this report, the global Human Coagulation Factor VIII market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Coagulation Factor VIII in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Human Coagulation Factor VIII market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Baxter
    Bayer
    Pfizer
    CSL Behring
    Grifols
    Octapharma
    BPL
    Kedrion
    Biogen
    NovoNordisk
    Greencross
    Hualan Bio
    Shire
    RAAS
    ProSpec
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Recombinant Factor VIII
    Plasma-derived Factor VIII
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Laboratory Research
    Surgical
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Human Coagulation Factor VIII Market Research Report 2017
1 Human Coagulation Factor VIII Market Overview
    1.1 Product Overview and Scope of Human Coagulation Factor VIII
    1.2 Human Coagulation Factor VIII Segment by Type (Product Category)
        1.2.1 Global Human Coagulation Factor VIII Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Human Coagulation Factor VIII Production Market Share by Type (Product Category) in 2016
        1.2.3 Recombinant Factor VIII
        1.2.4 Plasma-derived Factor VIII
    1.3 Global Human Coagulation Factor VIII Segment by Application
        1.3.1 Human Coagulation Factor VIII Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Laboratory Research
        1.3.3 Surgical
        1.3.4 Other
    1.4 Global Human Coagulation Factor VIII Market by Region (2012-2022)
        1.4.1 Global Human Coagulation Factor VIII Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Human Coagulation Factor VIII (2012-2022)
        1.5.1 Global Human Coagulation Factor VIII Revenue Status and Outlook (2012-2022)
        1.5.2 Global Human Coagulation Factor VIII Capacity, Production Status and Outlook (2012-2022)

2 Global Human Coagulation Factor VIII Market Competition by Manufacturers
    2.1 Global Human Coagulation Factor VIII Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Human Coagulation Factor VIII Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Human Coagulation Factor VIII Production and Share by Manufacturers (2012-2017)
    2.2 Global Human Coagulation Factor VIII Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Human Coagulation Factor VIII Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Human Coagulation Factor VIII Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Human Coagulation Factor VIII Market Competitive Situation and Trends
        2.5.1 Human Coagulation Factor VIII Market Concentration Rate
        2.5.2 Human Coagulation Factor VIII Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Coagulation Factor VIII Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Human Coagulation Factor VIII Capacity and Market Share by Region (2012-2017)
    3.2 Global Human Coagulation Factor VIII Production and Market Share by Region (2012-2017)
    3.3 Global Human Coagulation Factor VIII Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Human Coagulation Factor VIII Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Human Coagulation Factor VIII Consumption by Region (2012-2017)
    4.2 North America Human Coagulation Factor VIII Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Human Coagulation Factor VIII Production, Consumption, Export, Import (2012-2017)
    4.4 China Human Coagulation Factor VIII Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Human Coagulation Factor VIII Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Human Coagulation Factor VIII Production, Consumption, Export, Import (2012-2017)
    4.7 India Human Coagulation Factor VIII Production, Consumption, Export, Import (2012-2017)

5 Global Human Coagulation Factor VIII Production, Revenue (Value), Price Trend by Type
    5.1 Global Human Coagulation Factor VIII Production and Market Share by Type (2012-2017)
    5.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2012-2017)
    5.3 Global Human Coagulation Factor VIII Price by Type (2012-2017)
    5.4 Global Human Coagulation Factor VIII Production Growth by Type (2012-2017)

6 Global Human Coagulation Factor VIII Market Analysis by Application
    6.1 Global Human Coagulation Factor VIII Consumption and Market Share by Application (2012-2017)
    6.2 Global Human Coagulation Factor VIII Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Human Coagulation Factor VIII Manufacturers Profiles/Analysis
    7.1 Baxter
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Baxter Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bayer
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bayer Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Pfizer
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Pfizer Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 CSL Behring
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 CSL Behring Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Grifols
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Grifols Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Octapharma
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Octapharma Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 BPL
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 BPL Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Kedrion
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Kedrion Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Biogen
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Biogen Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 NovoNordisk
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Human Coagulation Factor VIII Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 NovoNordisk Human Coagulation Factor VIII Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Greencross
    7.12 Hualan Bio
    7.13 Shire
    7.14 RAAS
    7.15 ProSpec

8 Human Coagulation Factor VIII Manufacturing Cost Analysis
    8.1 Human Coagulation Factor VIII Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Human Coagulation Factor VIII

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Human Coagulation Factor VIII Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Human Coagulation Factor VIII Market Forecast (2017-2022)
    12.1 Global Human Coagulation Factor VIII Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Human Coagulation Factor VIII Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Human Coagulation Factor VIII Price and Trend Forecast (2017-2022)
    12.2 Global Human Coagulation Factor VIII Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Human Coagulation Factor VIII Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Human Coagulation Factor VIII Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Human Coagulation Factor VIII Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Human Coagulation Factor VIII Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Human Coagulation Factor VIII Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Human Coagulation Factor VIII Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Human Coagulation Factor VIII Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Human Coagulation Factor VIII Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer